Última atualização: Agosto 17, 2026
Реестр международных мультицентровых клинических исследований лекарств в России
Study List: Estudar 1: Título: A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Câncer|Cataract|Low Bone Mineral Density|Osteopenia|Osteoporose|Prostate Cancer Interventions: Biological: Denosumab|Biological: Placebo URL: http://ClinicalTrials.gov/show/NCT00925600 Study 2: Título: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Intra-Abdominal Infection Interventions: Medicamento: Moxifloxacin (Avelox, BAY12-8039)|Medicamento: Ertapenem, Amoxicillin/clavulanate URL: http://ClinicalTrials.gov/show/NCT01069900 Study 3: Título: A Study of LY2140023 in Patients With Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Medicamento: LY2140023|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01307800 Study 4: Título: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thrombosis Interventions: Medicamento: Enoxaparin|Medicamento: warfarin|Medicamento: Placebo for apixaban|Medicamento: Placebo for enoxaparin|Medicamento: Placebo for warfarin|Medicamento: apixaban URL: http://ClinicalTrials.gov/show/NCT00643201 Study 5: Título: LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Recruitment: Recruiting Study Results: No Results Available Conditions: or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Neoplasms, Gastrointestinal Tract|Esophageal Interventions: Medicamento: Lapatinib|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00680901 Study 6: Título: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Advanced Breast Cancer|Breast Cancer Interventions: Medicamento: Neratinib|Medicamento: Lapatinib|Medicamento: Capecitabine URL: http://ClinicalTrials.gov/show/NCT00777101 Study 7: Título: An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure Recruitment: Recruiting Study Results: No Results Available Conditions: Reversal of Coagulopathy Interventions: Biological: Beriplex® P/N|Biological: Fresh frozen plasma URL: http://ClinicalTrials.gov/show/NCT00803101 Study 8: Título: Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Medicamento: Interferon b 1a|Medicamento: DAC HYP URL: http://ClinicalTrials.gov/show/NCT01064401 Study 9: Título: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Renal Cell Carcinoma Interventions: Medicamento: Sunitinibe|Biological: IMA901 mais GM-CSF|Medicamento: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01265901 Study 10: Título: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: URL: http://ClinicalTrials.gov/show/NCT01394601 Study 11: Título: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Recruitment: Recruiting Study Results: No Results Available Conditions: Doenças Cardiovasculares|Doenças Cardíacas|Insuficiência cardíaca, Congestive Interventions: Medicamento: Antagonista da aldosterona (espironolactona)|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00094302 Study 12: Título: Uma Fase 3 Estudo de Brentuximabe Vedotin (SGN-35) em pacientes com alto risco de linfoma de Hodgkin residual após transplante de células-tronco (O ensaio AETHERA) Recrutamento: Recruiting Study Results: No Results Available Conditions: Doença, Hodgkin Interventions: Medicamento: brentuximabe vedotina|Medicamento: placebo URL: http://ClinicalTrials.gov/show/NCT01100502 Study 13: Título: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Convulsões|Epilepsia|Partial-Onset Seizures Interventions: Medicamento: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01227902 Study 14: Título: A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: LY2127399|Medicamento: Placebo every 2 semanas|Medicamento: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01198002 Study 15: Título: Study of Eniluracil + 5-Fluorouracila (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer Interventions: Medicamento: Eniluracil|Medicamento: 5-Fluorouracila|Medicamento: Leucovorin|Medicamento: Capecitabine URL: http://ClinicalTrials.gov/show/NCT01231802 Study 16: Título: A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Recruitment: Recruiting Study Results: No Results Available Conditions: Tumor|Pain Interventions: Medicamento: CG5503 ER|Medicamento: Placebo to match CG5503|Medicamento: Morphine Sulphate CR|Medicamento: Placebo to match Morphine Sulphate CR URL: http://ClinicalTrials.gov/show/NCT00472303 Study 17: Título: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: ATN-103|Medicamento: ATN-103 URL: http://ClinicalTrials.gov/show/NCT01063803 Study 18: Título: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Medicamento: rituximab [MabThera]|Medicamento: rituximab [MabThera]|Medicamento: rituximab [MabThera]|Medicamento: Fludarabine|Medicamento: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01292603 Study 19: Título: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Hepatitis B Virus, Pediatric Interventions: Medicamento: Entecavir|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01079806 Study 20: Título: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Recruitment: Recruiting Study Results: No Results Available Conditions: Alopécia|Androgenetic Alopecia Interventions: Medicamento: 1mg Finasteride active|Medicamento: 0.02mg dutasteride|Medicamento: 0.1mg dutasteride|Medicamento: 0.5mg dutasteride|Medicamento: Finasteride placebo|Medicamento: Dutasteride placebo URL: http://ClinicalTrials.gov/show/NCT01231607 Study 21: Título: Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Fibrilação atrial|Arritmia|Stroke Prevention|Mortality Interventions: Device: Left atrial ablation|Medicamento: Rate or Rhythm Control Therapy URL: http://ClinicalTrials.gov/show/NCT00911508 Study 22: Título: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Tipo 2|Acute Coronary Syndrome Interventions: Medicamento: Alogliptin|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00968708 Study 23: Título: Evaluation of Tiotropium 2.5 e 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Inalador de dose medida (MDI) (50 Mcg duas vezes ao dia) in Patient With Moderate Persistent Asthma I Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Medicamento: Placebo|Medicamento: Placebo|Medicamento: Placebo|Medicamento: Placebo|Medicamento: Placebo|Medicamento: 50 mcg salmeterol HFA MDI|Medicamento: 5 mcg tiotrópio Respimat®|Medicamento: 2.5 mcg tiotropium Respimat® URL: http://ClinicalTrials.gov/show/NCT01172808 Study 24: Título: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatocellular Carcinoma Interventions: Medicamento: sorafenibe|Biological: mapatumumab URL: http://ClinicalTrials.gov/show/NCT01258608 Study 25: Título: Estudo de letrozol com ou sem DP 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Medicamento: DP 0332991|Medicamento: letrozol|Medicamento: letrozole URL: http://ClinicalTrials.gov/show/NCT00721409 Study 26: Título: Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Câncer de Pulmão - Non Small Cell Interventions: Medicamento: Ipilimumab|Medicamento: Placebo|Medicamento: Paclitaxel|Medicamento: Carboplatin URL: http://ClinicalTrials.gov/show/NCT01285609 Study 27: Título: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease Interventions: Medicamento: bapineuzumab|Medicamento: bapineuzumab|Medicamento: placebo URL: http://ClinicalTrials.gov/show/NCT00667810 Study 28: Título: Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) Recrutamento: Recruiting Study Results: No Results Available Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL) Interventions: Medicamento: Lenalidomide|Medicamento: Chlorambucil URL: http://ClinicalTrials.gov/show/NCT00910910 Study 29: Título: A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Medicamento: rituximab [MabThera]|Medicamento: fludarabine|Medicamento: cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01271010 Study 30: Título: A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Neoplasms, Breast Interventions: Medicamento: lapatinib|Medicamento: trastuzumab|Medicamento: Aromatase inhibitor|Medicamento: lapatinib URL: http://ClinicalTrials.gov/show/NCT01160211 Study 31: Título: A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee Recruitment: Recruiting Study Results: No Results Available Conditions: Osteoarthritis Interventions: Medicamento: SD-6010|Medicamento: SD-6010|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00565812 Study 32: Título: Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Asthma Interventions: Medicamento: Placebo compatível com Respimat|Medicamento: Placebo compatível com Respimat|Medicamento: BI 54903 Médico|Medicamento: BI 54903 HD URL: http://ClinicalTrials.gov/show/NCT01458912 Study 33: Título: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure Interventions: Medicamento: Placebo|Medicamento: Omecamtiv mecarbil URL: http://ClinicalTrials.gov/show/NCT01300013 Study 34: Título: Study of Immunotherapy to Treat Advanced Prostate Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: Medicamento: Ipilimumab|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00861614 Study 35: Título: Fase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Non-small Cell Lung Cancer Interventions: Medicamento: Tavocept(BNP7787) em combinação com cisplatina e docetaxel ou paclitaxel|Medicamento: Placebo in combination with cisplatin and docetaxel or paclitaxel URL: http://ClinicalTrials.gov/show/NCT00966914 Study 36: Título: Uma eficácia, Segurança, e estudo de tolerabilidade da canagliflozina em pacientes com tipo 2 Diabetes Mellitus Who Have Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Tipo 2|Renal Insufficiency Interventions: Medicamento: Canagliflozina 100 mg|Medicamento: Canagliflozina 300 mg|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01064414 Study 37: Título: ACT-293987 in Pulmonary Arterial Hypertension Recruitment: Recruiting Study Results: No Results Available Conditions: Pulmonary Arterial Hypertension Interventions: Medicamento: ATO-293987|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01106014 Study 38: Título: A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: tocilizumab [RoActemra/Actemra]|Medicamento: tocilizumab [RoActemra/Actemra]|Medicamento: placebo|Medicamento: placebo|Medicamento: Medicamentos anti-reumáticos modificadores da doença (DMARDs) URL: http://ClinicalTrials.gov/show/NCT01194414 Study 39: Título: Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) Recrutamento: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: Fostamatinib|Medicamento: Fostamatinib|Medicamento: Fostamatinib URL: http://ClinicalTrials.gov/show/NCT01242514 Study 40: Título: RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Insuficiência cardíaca|Anemia|Doença Cardiovascular|Ventricular Dysfunction|Congestive Heart Failure Interventions: Medicamento: Darbepoetin alfa|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00358215 Study 41: Título: AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Medicamento: bevacizumabe [eu descobri]|Medicamento: pemetrexedo|Medicamento: cisplatin URL: http://ClinicalTrials.gov/show/NCT00961415 Study 42: Título: Estudo de ACT-129968 em pacientes adultos com asma parcialmente controlada. Recrutamento: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Medicamento: ATO-129968|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01225315 Study 43: Título: Um estudo de ixabepilona como terapia de segunda linha para localmente avançado, Recurrent or Metastatic Endometrial Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancer Interventions: Medicamento: Xabepilona|Medicamento: Doxorrubicina|Medicamento: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT00883116 Study 44: Título: Axitinibe (AG-013736) For the Treatment of Metastatic Renal Cell Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Neoplasms Interventions: Medicamento: Axitinibe (AG-013736)|Medicamento: Sorafenib URL: http://ClinicalTrials.gov/show/NCT00920816 Study 45: Título: Um estudo de GSK1349572 versus Raltegravir (RAL) Com regime de base selecionado pelo investigador em antirretrovirais experientes, Integrase Inhibitor-Naive Adults Recruitment: Recruiting Study Results: No Results Available Conditions: Infecção, Human Immunodeficiency Virus Interventions: Medicamento: GSK1349572|Medicamento: Raltegravir|Medicamento: GSK1349572 Placebo|Medicamento: Raltegravir Placebo URL: http://ClinicalTrials.gov/show/NCT01231516 Study 46: Título: Um estudo de rollover de BI 201335 em combinação com interferon-alfa peguilado e ribavirina em genótipo com experiência em tratamento 1 Hepatitis C Infected Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Medicamento: PegIFN/RBV|Medicamento: BI 201335 URL: http://ClinicalTrials.gov/show/NCT01330316 Study 47: Título: Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Esclerose múltipla|Relapsing-remitting Interventions: Medicamento: AIN457|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01051817 Study 48: Título: Um estudo sobre a eficácia e segurança do Xolair (Omalizumabe) em pacientes com urticária idiopática crônica (UIC)/Urticária Espontânea Crônica (CSU) Que permanecem sintomáticos apesar do tratamento anti-histamínico (H1) Recrutamento: Recruiting Study Results: No Results Available Conditions: Chronic Idiopathic Urticaria Interventions: Medicamento: omalizumabe|Medicamento: placebo URL: http://ClinicalTrials.gov/show/NCT01287117 Study 49: Título: Isavuconazol (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Recruitment: Recruiting Study Results: No Results Available Conditions: Micoses|Candidíase, Invasivo|Candidemia Interventions: Medicamento: Isavuconazol|Medicamento: Caspofungina|Medicamento: Voriconazole URL: http://ClinicalTrials.gov/show/NCT00413218 Study 50: Título: BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Neoplasias Ovarianas|Peritoneal Neoplasms Interventions: Medicamento: BIBF 1120|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01015118 Study 51: Título: Uma Imunogenicidade e Farmacocinética (PC) Estudo da seringa pré-cheia DAC HYP na esclerose múltipla recorrente-remitente (EMRR) Recrutamento: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Biological: Daclizumab High Yield Process prefilled syringe URL: http://ClinicalTrials.gov/show/NCT01462318 Study 52: Título: Study in Adolescents With Schizophrenia or Bipolar Disorder Recruitment: Recruiting Study Results: No Results Available Conditions: Bipolar I Disorder|Schizophrenia Interventions: Medicamento: Olanzapina|Behavioral: Standard behavioral weight intervention|Behavioral: Intense behavioral weight intervention URL: http://ClinicalTrials.gov/show/NCT00982020 Study 53: Título: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation Recruitment: Recruiting Study Results: No Results Available Conditions: Coronary Artery Disease Interventions: Medicamento: RVX000222|Medicamento: Placebo RVX000222 URL: http://ClinicalTrials.gov/show/NCT01067820 Study 54: Título: A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) Recrutamento: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Medicamento: RO4917838|Medicamento: RO4917838|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01235520 Study 55: Título: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy Recruitment: Recruiting Study Results: No Results Available Conditions: Hyperparathyroidism, Primary Interventions: Medicamento: cinacalcet HCl|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00975221 Study 56: Título: Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. Recrutamento: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: fostamatinib|Medicamento: fostamatinib|Medicamento: placebo, fostamatinib URL: http://ClinicalTrials.gov/show/NCT01197521 Study 57: Título: Long-Term Safety Study of Retigabine Immediate Release (E) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS). Recrutamento: Recruiting Study Results: No Results Available Conditions: Convulsões|Epilepsia|Partial-Onset Seizures Interventions: Medicamento: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01336621 Study 58: Título: Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer. Recrutamento: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer|Metástases, Brain Interventions: Medicamento: capecitabine|Medicamento: lapatinib|Medicamento: trastuzumab URL: http://ClinicalTrials.gov/show/NCT00820222 Study 59: Título: STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction Recruitment: Recruiting Study Results: No Results Available Conditions: Myocardial Infarction Interventions: Medicamento: tenecteplase|Medicamento: enoxaparin|Medicamento: clopidogrel|Procedimento: catheterisation|Procedimento: primary PCI URL: http://ClinicalTrials.gov/show/NCT00623623 Study 60: Título: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Esclerose múltipla, Relapsing-Remitting Interventions: Medicamento: ocrelizumabe|Medicamento: Rebif|Medicamento: ocrelizumab placebo|Medicamento: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01247324 Study 61: Título: CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Tipo 2 Interventions: Medicamento: linagliptin|Medicamento: glimepiride URL: http://ClinicalTrials.gov/show/NCT01243424 Study 62: Título: PANORAMA Observational Study Recruitment: Recruiting Study Results: No Results Available Conditions: Arritmia|Cardiac Pacemaker, Artificial|Defibrillators, Implantable Interventions: Device: Cardiac Pacemaker, Defibrillator, pacemaker lead URL: http://ClinicalTrials.gov/show/NCT00382525 Study 63: Título: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Câncer de pulmão de células não pequenas positivo para antígeno tumoral|Câncer de Pulmão, Non-Small Cell Interventions: Biological: Imunoterapêutico específico para câncer de antígeno GSK1572932A|Biological: Placebo Control URL: http://ClinicalTrials.gov/show/NCT00480025 Study 64: Título: Um estudo da qualidade de vida e resposta ao tratamento com NeoRecormon uma vez por semana (Epoetina Beta) Tratamento em pacientes anêmicos com doenças malignas sólidas e linfóides. Recrutamento: Recruiting Study Results: No Results Available Conditions: Anemia Interventions: Medicamento: epoetina beta [NeoRecormon]|Medicamento: epoetina beta [NeoRecormon] URL: http://ClinicalTrials.gov/show/NCT00776425 Study 65: Título: Tratamento Innohep® de longo prazo versus um antagonista da vitamina K (Varfarina) para o tratamento do tromboembolismo venoso (TEV) in Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thromboembolism Interventions: Medicamento: Varfarina|Medicamento: Innohep® URL: http://ClinicalTrials.gov/show/NCT01130025 Study 66: Título: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Medicamento: HIV therapy URL: http://ClinicalTrials.gov/show/NCT01275625 Study 67: Título: LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Neoplasms Interventions: Medicamento: Afatinib 40mg once daily (OD)|Medicamento: Vinorelbina 25 mg/m2 weekly|Medicamento: Paclitaxel 80 mg/m2 weekly URL: http://ClinicalTrials.gov/show/NCT01271725 Study 68: Título: A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung) Recrutamento: Not yet recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Medicamento: onartuzumab [MetMAb]|Medicamento: erlotinib [Tarceva]|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01456325 Study 69: Título: Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Biological: ramucirumab (IMC-1121B)|Medicamento: docetaxel|Outro: placebo URL: http://ClinicalTrials.gov/show/NCT00703326 Study 70: Título: ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing-remitting Multiple Sclerosis Interventions: Medicamento: ATO-128800|Medicamento: ATO-128800|Medicamento: ACT-128800 URL: http://ClinicalTrials.gov/show/NCT01093326 Study 71: Título: Um duplo-cego, Controlado por placebo, 2-estudo de um ano de galantamina usada para tratar pacientes com doença de Alzheimer leve a moderada. Recrutamento: Recruiting Study Results: No Results Available Conditions: Doença de Alzheimer|Demência, Alzheimer Type Interventions: Medicamento: Galantamina|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00679627 Study 72: Título: Um estudo sobre segurança e eficácia do ustecinumabe em pacientes adolescentes com psoríase (CADMO) Recrutamento: Recruiting Study Results: No Results Available Conditions: Psoriasis Interventions: Biological: ustecinumabe/placebo|Biological: ustecinumabe/placebo|Biological: ustekinumab/placebo URL: http://ClinicalTrials.gov/show/NCT01090427 Study 73: Título: PEARL Schizophrenia Maintenance Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Medicamento: Lurasidona|Medicamento: Matching Placebo URL: http://ClinicalTrials.gov/show/NCT01435928 Study 74: Título: Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Recruitment: Recruiting Study Results: No Results Available Conditions: Preterm Birth Interventions: Medicamento: Hydroxyprogesterone Caproate Injection, 250mg/mL|Medicamento: Vehicle URL: http://ClinicalTrials.gov/show/NCT01004029 Study 75: Título: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes Mellitus, Tipo 2 Interventions: Medicamento: aleglitazar|Medicamento: pioglitazone URL: http://ClinicalTrials.gov/show/NCT01043029 Study 76: Título: Roflumilast in Chronic Obstructive Pulmonary Disease (DPOC) Patients Treated With Fixed Combinations of Long-acting β2-agonists (DOIS) and Inhaled Glucocorticosteroid (ICS) Recrutamento: Recruiting Study Results: No Results Available Conditions: Chronic Obstructive Pulmonary Disease Interventions: Medicamento: Roflumilast|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01329029 Study 77: Título: A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Hodgkin's Lymphoma Interventions: Medicamento: bendamustine|Medicamento: RO5072759 URL: http://ClinicalTrials.gov/show/NCT01059630 Study 78: Título: Eficácia e segurança de 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Medicamento: 2.5 mcg tiotrópio Respimat|Medicamento: placebo Respimat|Medicamento: 2.5 mcg tiotropium Respimat URL: http://ClinicalTrials.gov/show/NCT01257230 Study 79: Título: TMC125IFD3002 - O Estudo VIOLINO: para avaliar a tolerabilidade da etravirina, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Medicamento: etravirine URL: http://ClinicalTrials.gov/show/NCT01422330 Study 80: Título: Study of Paclitaxel in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Câncer Epitelial de Ovário|Câncer Peritoneal Primário|Fallopian Tube Cancer Interventions: Medicamento: Paclical®|Medicamento: Taxol® URL: http://ClinicalTrials.gov/show/NCT00989131 Study 81: Título: Um estudo da adição de Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Cancer Interventions: Medicamento: bevacizumabe [eu descobri]|Medicamento: carboplatina|Medicamento: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT01239732 Study 82: Título: Asthma in Children Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: URL: http://ClinicalTrials.gov/show/NCT01286532 Study 83: Título: A Study of MabThera (Rituximab) em pacientes com artrite reumatóide que tiveram uma resposta inadequada a um único inibidor anti-TNF. Recrutamento: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: rituximab [MabThera/Rituxan]|Medicamento: Methotrexate URL: http://ClinicalTrials.gov/show/NCT00576433 Study 84: Título: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Esclerose múltipla, Relapsing-Remitting Interventions: Medicamento: ocrelizumabe|Medicamento: Rebif|Medicamento: ocrelizumab placebo|Medicamento: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01412333 Study 85: Título: Estudo de carboplatina/paclitaxel em combinação com ABT-869 em indivíduos com câncer de pulmão de células não pequenas avançado ou metastático (CPNPC) Recrutamento: Recruiting Study Results: No Results Available Conditions: Advanced or Metastatic Non-Small Cell Lung Cancer Interventions: Medicamento: ABT-869|Medicamento: Placebo para ABT-869|Medicamento: ABT-869 URL: http://ClinicalTrials.gov/show/NCT00716534 Study 86: Título: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: URL: http://ClinicalTrials.gov/show/NCT01320735 Study 87: Título: Um estudo de segurança e eficácia do CNTO 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease Recruitment: Recruiting Study Results: No Results Available Conditions: Castleman's Disease Interventions: Outro: Placebo|Medicamento: CNT 328 URL: http://ClinicalTrials.gov/show/NCT01024036 Study 88: Título: Avaliação de SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Medicamento: SAR153191 (REGN88)|Medicamento: placebo URL: http://ClinicalTrials.gov/show/NCT01061736 Study 89: Título: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Transplantation Interventions: Medicamento: Advagraf|Medicamento: Micofenolato Mofetil|Medicamento: Simulect|Medicamento: Corticosteroids URL: http://ClinicalTrials.gov/show/NCT01304836 Study 90: Título: Study of the Combination of Rituximab, Ciclofosfamida, Doxorrubicina, VELCADE, and Prednisone or Rituximab, Ciclofosfamida, Doxorrubicina, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Mantle Cell Lymphoma Interventions: Medicamento: Rituximab, Ciclofosfamida, Doxorrubicina, VELCADE, and Prednisone|Medicamento: Rituximab, Ciclofosfamida, Doxorrubicina, Vincristine and Prednisone URL: http://ClinicalTrials.gov/show/NCT00722137 Study 91: Título: Um duplo-cego, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects Recruitment: Recruiting Study Results: No Results Available Conditions: DLBCL Interventions: Biological: TL011|Biological: Rituximab URL: http://ClinicalTrials.gov/show/NCT01205737 Study 92: Título: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Medicamento: Sorafenib(Nexavar, BAY43-9006) / Capecitabine|Medicamento: Placebo / Capecitabine URL: http://ClinicalTrials.gov/show/NCT01234337 Study 93: Título: A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Recruitment: Recruiting Study Results: No Results Available Conditions: Doença Cardiovascular, Rheumatoid Arthritis Interventions: Medicamento: tocilizumab [RoActemra/Actemra]|Medicamento: etanercept URL: http://ClinicalTrials.gov/show/NCT01331837 Study 94: Título: Pregabalin Versus Levetiracetam In Partial Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Partial Seizures Interventions: Medicamento: pregabalin|Medicamento: levetiracetam URL: http://ClinicalTrials.gov/show/NCT00537238 Study 95: Título: A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis Recruitment: Recruiting Study Results: No Results Available Conditions: Parkinson's Disease Psychosis Interventions: Medicamento: pimavanserin tartrate (ACP-103) URL: http://ClinicalTrials.gov/show/NCT00550238 Study 96: Título: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Recruitment: Recruiting Study Results: No Results Available Conditions: Tipo 2 Diabetes Mellitus Interventions: Medicamento: Exenatida uma vez por semana|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01144338 Study 97: Título: A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Recruitment: Recruiting Study Results: No Results Available Conditions: Lúpus Eritematoso Sistêmico|Doença do Tecido Conjuntivo|Autoimmune Disease Interventions: Medicamento: LY2127399|Medicamento: Placebo every 2 semanas|Medicamento: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01205438 Study 98: Título: Study of FP-1039 in Subjects With Endometrial Cancers Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancers With FGFR2 Mutations Interventions: Medicamento: FP-1039 URL: http://ClinicalTrials.gov/show/NCT01244438 Study 99: Título: TMC435HPC3007 - Ensaio de Fase III de TMC435 no Genótipo 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Medicamento: TMC435|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT01281839 Study 100: Título: Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Recruitment: Recruiting Study Results: No Results Available Conditions: Colorectal Cancer Interventions: Medicamento: CS-7017|Medicamento: Placebo URL: http://ClinicalTrials.gov/show/NCT00986440
Revisão de Caso Científico
Você gostaria de entender se os programas clínicos atuais, desenvolvimentos de pesquisa recentes, ou abordagens emergentes podem ser relevante para sua situação individual?
Envie sua dúvida para nossa equipe científica. A sede da NBScience no Reino Unido coordena consultas em toda a rede internacional de centros médicos, cientistas, e consultores especializados.
- Revisão das informações que você fornece
- Informações relevantes sobre pesquisas e programas clínicos
- Uma resposta clara focada na sua situação
O que acontece a seguir?
Envie sua pergunta, receber uma revisão científica focada, e obter uma resposta clara sobre pesquisas e programas clínicos relevantes para sua situação.
Sua revisão científica será preparada por Dr.. Helen Melnik,Doutorado , quem tem mais de 25 anos de experiência em pesquisa com células-tronco e programas clínicos internacionais.
Sem obrigação. Sua pergunta será analisada confidencialmente.
Apenas informações educacionais e de pesquisa. Este serviço não constituem aconselhamento médico, diagnóstico, prescrição, ou um personalizado recomendação de tratamento.
